Joined December 2015
- Tweets 433
- Following 105
- Followers 1,634
- Likes 284
24 Photos and videos
Thank you to @CARB_X developers, partners, and investors who gathered in Vienna, Austria on April 10 for CARB-X's annual Investor Day! More than 20 developers in advanced product stages presented to downstream investors interested in supporting antimicrobial products.
1
3
4
684
24 Jan 2025
2
1
486
Vedanta Biosciences retweeted
18 Dec 2024
If you have mild to moderate #ulcerativecolitis, and have not taken biologic medications or Janus Kinase (JAK) inhibitors, the VE202 study may be right for you. Learn more: bit.ly/3ZZ0FqD #sponsored #ulcerativecolitis #VE202 #UC
5
6
1,474
Vedanta Biosciences retweeted
18 Oct 2024
The Vedanta team is very excited to share our latest findings coming out of our successful VE303 Ph2 study in CDI. #IDWeek2024
17 Oct 2024
Vedanta Biosciences To Present at IDWeek 2024 on Benefit of VE303 on Antibiotic Resistant Gene Levels in Patient Microbiomes
businesswire.com/news/home/2β¦
4
9
1,294
Vedanta Biosciences retweeted
17 Oct 2024
This analysis show the positive impact of VE303 treatment on the levels of antibiotic resistance genes in the gut microbiomes of patients enrolled in the Ph2 CONSORTIUM study, revealing associations between higher dosage and colonization of VE303 strains with lower levels of ARGs
1
1
581
Vedanta Biosciences retweeted
17 Oct 2024
@themissingmenon will be giving the late-breaking oral presentation this Friday in LA as part of Infectious Diseases Week (IDWeek) 2024
1
1
1
290
Vedanta Biosciences retweeted
17 Oct 2024
Vedanta Biosciences To Present at IDWeek 2024 on Benefit of VE303 on Antibiotic Resistant Gene Levels in Patient Microbiomes
businesswire.com/news/home/2β¦
1
2
5
1,683
Vedanta Biosciences retweeted
8 Oct 2024
We are recruiting a Bioinformatician to join our Systems Biology team at Vedanta. Come work with us to advance defined bacterial consortia as a new drug modality!
job-boards.greenhouse.io/vedβ¦
4
4
477
Vedanta Biosciences retweeted
8 Oct 2024
I am looking to hire a Bioinformatics Scientist to join the Systems Biology team @VedantaBio. Considering candidates in Boston area and up to 100% remote, if in US. Apply today! Please share! job-boards.greenhouse.io/vedβ¦
8
8
1,897
Vedanta Biosciences retweeted
3 Oct 2024
πππ₯π€π’π§π πππ’ππ§ππ: @VedantaBio's founder and CEO @bernatolle shares an expert take on microbiome drug development.
Full video: biotechtv.com/post/vedanta-bβ¦
3
11
2,383
Vedanta Biosciences retweeted
19 Sep 2024
We are excited to announce the publication of our new article today:
nature.com/articles/s41586-0β¦
7
35
152
16,508
Vedanta Biosciences retweeted
18 Sep 2024
Exciting collab with @Honda1Kenyaβs lab, out today in @Nature: A set of microbial strains taken from a human faecal donor can decolonize multidrug-resistant Enterobacteriaceae in the gut, including species associated with #IBD. (1/3) nature.com/articles/s41586-0β¦
3
83
245
27,696
Vedanta Biosciences retweeted
23 Jul 2024
2
10
920
Vedanta Biosciences retweeted
21 May 2024
2
2
438
Vedanta Biosciences retweeted
21 May 2024
We did not have a blueprint for how to get an LBP ready for a registrational study. In the last couple of years, the process development, analytical development, manufacturing, and quality teams @vedantabio worked tirelessly navigating uncharted waters /7
1
2
4
422
Vedanta Biosciences retweeted
21 May 2024
The Phase 3 study, RESTORATiVE303, is now underway in the US. We plan to expand enrollment to include >20 countries. It is a registrational study designed to support a BLA submission
/6
1
2
3
257
Vedanta Biosciences retweeted
21 May 2024
In the Phase 2 CONSORTIUM Study, VE303 demonstrated strong evidence of efficacy and a good safety profile, and so the VE303 high dose has been advanced to Phase 3 development /5
1
2
4
229
Vedanta Biosciences retweeted
21 May 2024
VE303 is a potential first-in-class Live Biotherapeutic Product consisting of an 8-strain defined bacterial consortium. "Defined" means the product has a specific, known composition of bacterial strains.
Each capsule contains the same strains, at a consistent dose /4
1
2
4
201
Vedanta Biosciences retweeted
21 May 2024
Fecal Microbiota Products are made from donor feces. We believe this has inherent limitations around commercial scalability, risk of pathogen transfer, and batch-to-batch variability.
We hope to advance the field with DEFINED products which obviate the need for donors /3
1
3
4
569
Vedanta Biosciences retweeted
21 May 2024
FDA has approved two Fecal Microbiota Products for rCDI, which provide patients access to an alternative to unregulated FMT
fda.gov/vaccines-blood-biolo⦠/2
1
2
2
174